Clinical Trial Update: Potential Osteocatabolic Effect Caused by Anti-CGRP mAbs in Migraine Patients Treated With Anti-CGRP mAbs - an Observational Pilot Project With Prospectively Collected Health Related Data

View source ↗

Summary

An observational pilot study to explore potential bone metabolism (osteocatabolic) effects in migraine patients treated with anti-CGRP monoclonal antibodies, us…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Ente Ospedaliero Cantonale, Bellinzona | Conditions: Migraine Disorders | Status: ACTIVE_NOT_RECRUITING